THYMIC CANCER

Clinical trials for THYMIC CANCER explained in plain language.

Never miss a new study

Get alerted when new THYMIC CANCER trials appear

Sign up with your email to follow new studies for THYMIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

Experimental cancer combo shows early promise but study halted

Disease control Terminated

This early-phase trial tested a new drug called nanrilkefusp alfa, which helps activate immune cells, both alone and combined with the immunotherapy pembrolizumab. It included 115 people with various advanced solid tumors that had stopped responding to standard treatments. The st…

Matched conditions: THYMIC CANCER

Phase: PHASE1 • Sponsor: SOTIO Biotech AG • Aim: Disease control

Last updated Jun 27, 2026 12:01 UTC

THYMIC CANCER

Get alerted when new THYMIC CANCER trials appear

Experimental cancer combo shows early promise but study halted